Publication Venue For
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: Week 48 outcomes from ACTG 5353
Valaciclovir therapy for herpes encephalitis: Caution advised
Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: Analysis of trends and outcomes
Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK
Virological efficacy of PI monotherapy for HIV-1 in clinical practice
Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: A retrospective observational cohort study of the Mycoses Study Group (MSG-12)
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes
Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials
Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: A tri-centre cohort study
Treatment of congenital cytomegalovirus infection: Implications for future therapeutic strategies
Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance
De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia
Activity of posaconazole in the treatment of central nervous system fungal infections
Bactericidal activity of levofloxacin against Mycoplasma pneumoniae 
2-Alkoxycarbonylaminopyridines: Inhibitors of Mycobacterium tuberculosis FtsZ
Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase
Susceptibility of Chlamydia trachomatis to trovafloxacin
Susceptibility of Chlamydia trachomatis to trovafloxacin.
. 39 Suppl B:63-65.
New therapeutic approaches to the alphaherpesvirus infections
Drug discovery for human immunodeficiency virus infection: Conquests and hurdles
Antiviral resistance: Mechanisms, clinical significance, and future implications
Efficacy of clarithromycin against Mycoplasma pneumoniae.
. 27 Suppl A:47-59.
Nebulized pentamidine as prophylaxis for pneumocystis carinii pneumonia
Treatment of human herpesvirus infections with special reference to encephalitis
Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: Vidarabine versus acyclovir